Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fahey

Showing results (511-520 of 552) with videos related to

Pageof 56
Sort By:
Annals of Surgical Oncology|May 24, 2014
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumorsDavid A Kleiman, Toni Beninato, Samuel Sultan, et al.
Endocrine-Related Cancer|January 29, 2019
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumorsBrendan M Finnerty, Maureen D Moore, Akanksha Verma, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2024
Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and RecurrenceYeon J Lee-Saxton, Caitlin E Egan, Brenden A Bratton, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical CarcinomaMichael J P Crowley, Theresa Scognamiglio, Yi-Fang Liu, et al.
Thyroid : Official Journal of the American Thyroid Association|June 11, 2015
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision MakingRobert L Ferris, Zubair Baloch, Victor Bernet, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 17, 2018
Clinical laboratory and imaging evidence for effectiveness of agarose-agarose macrobeads containing stem-like cells derived from a mouse renal adenocarcinoma cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer: Evaluation of a biological-systems approach to cancer therapy (U.S. FDA IND-BB 10091; NCT 02046174, NCT 01053013)Barry H Smith, Lawrence S Gazda, Thomas J Fahey, et al.
World Journal of Surgery|October 24, 2017
Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid CarcinomaMaureen D Moore, Emily Postma, Katherine D Gray, et al.
Surgical Endoscopy|February 1, 2022
Quantifying physiologic parameters of the gastroesophageal junction during re-operative anti-reflux surgeryJacques A Greenberg, Dessislava I Stefanova, Fernando Valle Reyes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2017
CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid TumorsIrene M Min, Enda Shevlin, Yogindra Vedvyas, et al.
Scientific Reports|July 25, 2019
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapyYogindra Vedvyas, Jaclyn E McCloskey, Yanping Yang, et al.
Pageof 56

Showing results (511-520 of 552) with videos related to

Sort By:
Pageof 56
Annals of Surgical Oncology|May 24, 2014
Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumorsDavid A Kleiman, Toni Beninato, Samuel Sultan, et al.
Endocrine-Related Cancer|January 29, 2019
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumorsBrendan M Finnerty, Maureen D Moore, Akanksha Verma, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2024
Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and RecurrenceYeon J Lee-Saxton, Caitlin E Egan, Brenden A Bratton, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical CarcinomaMichael J P Crowley, Theresa Scognamiglio, Yi-Fang Liu, et al.
Thyroid : Official Journal of the American Thyroid Association|June 11, 2015
American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision MakingRobert L Ferris, Zubair Baloch, Victor Bernet, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 17, 2018
Clinical laboratory and imaging evidence for effectiveness of agarose-agarose macrobeads containing stem-like cells derived from a mouse renal adenocarcinoma cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer: Evaluation of a biological-systems approach to cancer therapy (U.S. FDA IND-BB 10091; NCT 02046174, NCT 01053013)Barry H Smith, Lawrence S Gazda, Thomas J Fahey, et al.
World Journal of Surgery|October 24, 2017
Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid CarcinomaMaureen D Moore, Emily Postma, Katherine D Gray, et al.
Surgical Endoscopy|February 1, 2022
Quantifying physiologic parameters of the gastroesophageal junction during re-operative anti-reflux surgeryJacques A Greenberg, Dessislava I Stefanova, Fernando Valle Reyes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2017
CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid TumorsIrene M Min, Enda Shevlin, Yogindra Vedvyas, et al.
Scientific Reports|July 25, 2019
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapyYogindra Vedvyas, Jaclyn E McCloskey, Yanping Yang, et al.
Pageof 56